ATP-sensitive potassium channel blockage attenuates cisplatin-induced renal damage

Kidney and Blood Pressure Research

Volumn 30, Issue 5, 2007, Pages 289-298

  Flávio, Andréa G C ^a   Cunha, Fernando Q ^a   Francescato, Heloísa D Colletta ^a   Soares, Telma J ^a   Costa, Roberto S ^a   Barbosa Jr , Fernando ^a   Coimbra, Terezila M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute renal failure; Cisplatin; Cytokines; Glibenclamide; Inflammation; Nephrotoxicity; Neutrophils

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CISPLATIN; GLIBENCLAMIDE; INTERLEUKIN 1BETA; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY TUBULE NECROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY INJURY; MACROPHAGE; MALE; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CISPLATIN; KIDNEY DISEASES; MALE; NEUTROPHIL ACTIVATION; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, WISTAR;

EID: 34748891794     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000105816     Document Type: Article

References (36)

1. Meyer KB, Madias NE: Cisplatin nephrotoxicity. Miner Electrolyte Metab 1994;20:201-213.
2. Blachley JD, Hill JB: Renal and electrolyte disturbances associated with cisplatin. Ann Intern Med 1981;95:628-632.
3. Chopra S, Kaufman JS, Jones TW, Hong WK, Gehr MK, Hamburger RJ, Flamenbaum W, Trump BF: Cis-diamminedichloroplatinum-induced acute renal failure in the rat. Kidney Int 1982;21:54-64.
4. Leibbrandt ME, Wolfgang GH, Metz AL, Ozobia AA, Haskins JR: Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cells. Kidney Int 1995;48:761-770.
5. Hannemann J, Baumann K: Nephrotoxicity of cisplatin, carboplatin and transplatin. A comparative in vitro study. Arch Toxicol 1990;64:393-400.
6. Lierberthal W, Triaca V, Levine J: Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am J Physiol 1996;270:F700-F708.
7. Taguchi T, Nazneen A, Ruhul-Abid M, Razzaque MS: Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol 2005;148:107-121.
8. Francescato HDC, Coimbra TM, Costa RS, Bianchi MLP: Protective effect of quercetin on the evolution of cisplatin-induced acute tubular necrosis. Kidney Blood Press Res 2004;27:148-158.
9. Ramesh G, Reeves WB: TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 2002;110:835-842.
10. Li S, Gokden N, Okusa MD, Bhatt R, Portilla D: Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF. Am Renal J Physiol 2005;289:F469-F480.
11. Da Silva-Santos JE, Santos-Silva MC, Cunha FQ, Assreuy J: The role of ATP-sensitive potassium channels in neutrophil migration and plasma exudation. J Pharmacol Exp Ther 2002;300:946-951.
12. Majander A, Wikström M: The plasma membrane potential of human neutrophils. Role of ions channels and sodium/potassium pump. Biochem Biophys Acta 1989;980:139-145.
13. Chandler DE, Kazilek CJ: Calcium signals in neutrophils can be divided into three distinct phases. Biochim Biophys Acta 1987;931:175-179.
14. Lazzari KG, Proto P, Simmons ER: Neutrophil hyperpolarization in response to a chemotactic peptide. J Biol Chem 1990;265:10959-10967.
15. Souza DG, Cara DC, Cassali GD, Coutinho SF, Silveira MR, Andrade SP, Poole SP, Teixeira MM: Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischemia of superior mesenteric artery in the rat. Br J Pharmacol 2000;131:1800-1808.
16. Hartree EF: Determination of protein: a modification of Lowry method that gives a linear photometric response. Anal Biochem 1972;48:422-427.
17. Rees GS, Gee CK, Ward HL, Ball C, Tarrant GM, Poole S, Bristow AF: Rat tumor necrosis factor-alpha: expression in recombinant Pichia pastoris , purification, characterization and development of a novel ELISA. Eur Cytokine Netw 1999;10:383-392.
18. Baroni EA, Costa RS, Da Silva CGA, Coimbra TM: Heparin treatment reduces glomerular injury in rats with adriamycin-induced nephropathy but does not modify tubulointerstitial damage or the renal production of transforming growth factor-beta. Nephron 2000;84:248-257.
19. Coimbra TM, Janssen U, Gröne HJ, Ostendorf T, Kunter U, Schmidt H, Brabant G, Floege J: Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 2000;57:167-182.
20. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
21. Francescato HDC, Costa RS, Barbosa Jr F, Coimbra TM: Effect of JNK inhibition on cisplatin-induced renal damage. Nephrol Dial Transplant 2007, Epub ahead of print.
22. Haygen HN: The determination of 'endogenous creatinine' in plasma and urine. Scand J Clin Lab Invest 1953;5:48-57.
23. Füehr Y, Kaczmarszk Y, Kruttgen GD: Eine einfache colorimetrische Methode zur Inulin-Bestimmung für Nieren-Clearance-Untersuchungen bei Stoffwechselgesunden und Diabetikern. Klin Wochenschr 1955;33:729-730.
24. Rodrigues M, Barbosa F Jr, Perussi JR: Dipyridamole increases the cytotoxicity of cisplatin in human larynx cancer cells in vitro. Braz J Med Biol Res 2004;37:591-599.
25. Mistry P, Lee C, McBrien DC: Intracellular metabolites of cisplatin in the rat kidney. Cancer Chemother Pharmacol 1989;24:73-79.
26. McGahan MC, Tyczkowska KT: The determination of platinum in biological materials by electrothermal atomic absorption spectroscopy. Spectrochimica Acta 1987;42B:665-668.
27. Lauriat S, Linas SL: The role of neutrophis in acute renal failure. Sem Nephrol 1998;18:498-504.
28. Chilvers ER, Cadwallader KA, Reed BJ, White JP, Condliffe AM: The function and fate of neutrophils at inflamed site: prospects for therapeutic intervention. J R Coll Physisians Lond 2000;34:68-74.
29. Pompermayer K, Souza DG, Lara GG, Silveira KD, Cassali GD, Andrade AA, Bonjardim CA, Passaglio KT, Assreuy J, Cunha FQ, Vieira MAR, Teixeira MM: The ATP-sensitive potassium channel blocker glibenclamide prevents renal ischemia/referfusion injury in rats. Kidney Int 2005;67:1785-1796.
30. Eddy AA: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996;7:2495-2508.
31. Geleilete TJM, Melo GC, Costa RS, Volpini RA, Soares TJ, Coimbra TM: Role of myofibroblasts, macrophages, transforming growth factor-beta, endothelin, angiotensin-II, and fibronectin in the progression of tubulointerstitial nephritis induced by gentamicin. J Nephrol 2002;15:633-642.
32. Nikolic-Patterson DJ, Lan HY, Hill PA, Atkins RC: Macrophages in renal injury. Kidney Int 1994;45(suppl):S79-S82.
33. Eardley KS, Cockwell P: Macrophages and progressive tubulointerstitial disease. Kidney Int 2005;68:437-455.
34. Vaage J, Lindblad WJ: Production of collagen type I by mouse peritoneal macrophages. J Leukocyte Biol 1990;48:274-280.
35. Kishore BK, Krane CM, Di Iulio D, Menon AG, Cacini W: Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria. Kidney Int 2000;58:701-711.
36. Neto MM, Costa RS, Volpini RA, Garcia TMP, Rodrigues FF, Coimbra TM: Interstitial alterations in renal cortex in acute tubular necrosis (ATN) post-renal transplantation and in patients with ATN not related to renal transplant. Clin Transplant 2004;18:156-165.